- Home
- CVM vs CLSD Comparison
CVM vs CLSD Comparison
Compare CVM & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVM
- CLSD
- Stock Information
- Founded
- CVM 1983
- CLSD 2011
- Country
- CVM United States
- CLSD United States
- Employees
- CVM N/A
- CLSD N/A
- Industry
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- CVM Health Care
- CLSD Health Care
- Exchange
- CVM Nasdaq
- CLSD Nasdaq
- Market Cap
- CVM 71.2M
- CLSD 68.4M
- IPO Year
- CVM 1987
- CLSD 2016
- Fundamental
- Price
- CVM $9.91
- CLSD $3.63
- Analyst Decision
- CVM
- CLSD Hold
- Analyst Count
- CVM 0
- CLSD 4
- Target Price
- CVM N/A
- CLSD $4.33
- AVG Volume (30 Days)
- CVM 294.7K
- CLSD 652.7K
- Earning Date
- CVM 08-14-2025
- CLSD 11-11-2025
- Dividend Yield
- CVM N/A
- CLSD N/A
- EPS Growth
- CVM N/A
- CLSD N/A
- EPS
- CVM N/A
- CLSD N/A
- Revenue
- CVM N/A
- CLSD $4,166,000.00
- Revenue This Year
- CVM N/A
- CLSD $98.20
- Revenue Next Year
- CVM N/A
- CLSD $213.77
- P/E Ratio
- CVM N/A
- CLSD N/A
- Revenue Growth
- CVM N/A
- CLSD N/A
- 52 Week Low
- CVM $1.98
- CLSD $0.29
- 52 Week High
- CVM $38.70
- CLSD $4.43
- Technical
- Relative Strength Index (RSI)
- CVM 51.86
- CLSD 23.94
- Support Level
- CVM N/A
- CLSD $4.68
- Resistance Level
- CVM $10.48
- CLSD $5.33
- Average True Range (ATR)
- CVM 1.11
- CLSD 0.46
- MACD
- CVM -0.64
- CLSD -0.05
- Stochastic Oscillator
- CVM 73.74
- CLSD 1.58
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.